Pathophysiology and Treatment of Tinnitus: An Elusive Disease

Indian Journal of Otolaryngology and Head and Neck Surgery

Volumn 66, Issue SUPPL.1, 2014, Pages 1-5

  Atik, Alp ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Pathophysiology; Tinnitus; Treatment

Indexed keywords

EID: 84893747128     PISSN: 22313796     EISSN: 09737707     Source Type: Journal    
DOI: 10.1007/s12070-011-0374-8     Document Type: Review

References (41)

1. Crummer RW, Hassan GA (2004) Diagnostic approach to tinnitus. Am Fam Physician 69(1): 120-126.
2. Coles RR (1984) Epidemiology of tinnitus: (1) prevalence. J Laryngol Otol Suppl 9: 7-15.
3. Axelsson A, Ringdahl A (1989) Tinnitus-a study of its prevalence and characteristics. Br J Audiol 23(1): 53-62.
4. Cronlein T, Langguth B, Geisler P, Hajak G (2007) Tinnitus and insomnia. Prog Brain Res 166: 227-233.
5. Langguth B, Kleinjung T, Fischer B, Hajak G, Eichhammer P, Sand PG (2007) Tinnitus severity, depression, and the big five personality traits. Prog Brain Res 166: 221-225.
6. Claussen CF (2008) Rakel & Bope: Conn's Current Therapy, 60th edn. Elsevier Inc., Philadelphia.
7. Jacobson GP, McCaslin DL (2001) A search for evidence of a direct relationship between tinnitus and suicide. J Am Acad Audiol 12(10): 493-496.
8. Lockwood AH (2005) Tinnitus. Neurol Clin 23(3): 893-900 viii.
9. Ahmad N, Seidman M (2004) Tinnitus in the older adult: epidemiology, pathophysiology and treatment options. Drugs Aging 21(5): 297-305.
10. Lockwood AH, Salvi RJ, Burkard RF, Galantowicz PJ, Coad ML, Wack DS (1999) Neuroanatomy of tinnitus. Scand Audiol Suppl 51: 47-52.
11. Shulman A, Goldstein B (1997) Medical Significance of Tinnitus. Int Tinnitus J 3(1): 45-50.
12. Schleuning AJ 2nd (1991) Management of the patient with tinnitus. Med Clin North Am 75(6): 1225-1237.
13. Henry JA, Dennis KC, Schechter MA (2005) General review of tinnitus: prevalence, mechanisms, effects, and management. J Speech Lang Hear Res 48(5): 1204-1235.
14. Qiu C, Salvi R, Ding D, Burkard R (2000) Inner hair cell loss leads to enhanced response amplitudes in auditory cortex of unanesthetized chinchillas: evidence for increased system gain. Hear Res 139(1-2): 153-171.
15. Fortune DS, Haynes DS, Hall JW 3rd, Tinnitus (1999) Current evaluation and management. Med Clin North Am 83(1): 153-162 x.
16. Moller AR (1997) Similarities between chronic pain and tinnitus. Am J Otol 18(5): 577-585.
17. Konig O, Schaette R, Kempter R, Gross M (2006) Course of hearing loss and occurrence of tinnitus. Hear Res 221(1-2): 59-64.
18. Norena A, Micheyl C, Chery-Croze S, Collet L (2002) Psychoacoustic characterization of the tinnitus spectrum: implications for the underlying mechanisms of tinnitus. Audiol Neurootol 7(6): 358-369.
19. Roberts LE, Moffat G, Bosnyak DJ (2006) Residual inhibition functions in relation to tinnitus spectra and auditory threshold shift. Acta Otolaryngol Suppl 556: 27-33.
20. Langguth B, Salvi R, Elgoyhen AB (2009) Emerging pharmacotherapy of tinnitus. Expert Opin Emerg Drugs 14(4): 687-702.
21. Dobie RA (1999) A review of randomized clinical trials in tinnitus. Laryngoscope 109(8): 1202-1211.
22. Dobie R (2004) In: Snow J (ed) Tinnitus: theory and management. Decker, Hamilton.
23. Jastreboff PJ, Gray WC, Gold SL (1996) Neurophysiological approach to tinnitus patients. Am J Otol 17(2): 236-240.
24. Simpson JJ, Davies WE (2000) A review of evidence in support of a role for 5-HT in the perception of tinnitus. Hear Res 145(1-2): 1-7.
25. Thompson GC, Thompson AM, Garrett KM, Britton BH (1994) Serotonin and serotonin receptors in the central auditory system. Otolaryngol Head Neck Surg 110(1): 93-102.
26. Woods CI, Azeredo WJ (1999) Noradrenergic and serotonergic projections to the superior olive: potential for modulation of olivocochlear neurons. Brain Res 836(1-2): 9-18.
27. Baldo P, Doree C, Lazzarini R, Molin P, McFerran DJ (2006) Antidepressants for patients with tinnitus. Cochrane Database Syst Rev (4): CD003853.
28. Murai K, Tyler RS, Harker LA, Stouffer JL (1992) Review of pharmacologic treatment of tinnitus. Am J Otol 13(5): 454-464.
29. Yilmaz I, Akkuzu B, Cakmak O, Ozluoglu LN (2004) Misoprostol in the treatment of tinnitus: a double-blind study. Otolaryngol Head Neck Surg 130(5): 604-610.
30. Bauer CA, Brozoski TJ (2006) Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 116(5): 675-681.
31. Sanchez TG, Balbani AP, Bittar RS, Bento RF, Camara J (1999) Lidocaine test in patients with tinnitus: rationale of accomplishment and relation to the treatment with carbamazepine. Auris Nasus Larynx 26(4): 411-417.
32. Garduno-Anaya MA, Couthino De Toledo H, Hinojosa-Gonzalez R, Pane-Pianese C, Rios-Castaneda LC (2005) Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 133(2): 285-294.
33. Rejali D, Sivakumar A, Balaji N (2004) Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clin Otolaryngol Allied Sci 29(3): 226-231.
34. Berry JA, Gold SL, Frederick EA, Gray WC, Staecker H (2002) Patient-based outcomes in patients with primary tinnitus undergoing tinnitus retraining therapy. Arch Otolaryngol Head Neck Surg 128(10): 1153-1157.
35. Andersson G, Lyttkens L (1999) A meta-analytic review of psychological treatments for tinnitus. Br J Audiol 33(4): 201-210.
36. Zachriat C, Kroner-Herwig B (2004) Treating chronic tinnitus: comparison of cognitive-behavioural and habituation-based treatments. Cogn Behav Ther 33(4): 187-198.
37. Vio M (2003) Tinnitus market situation analysis. Royal National Institute of Deafness, London.
38. Elgoyhen AB, Vetter DE, Katz E, Rothlin CV, Heinemann SF, Boulter J (2001) alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci USA 98(6): 3501-3506.
39. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S (1994) Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79(4): 705-715.
40. Plazas PV, Savino J, Kracun S, Gomez-Casati ME, Katz E, Parsons CG et al (2007) Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors. Eur J Pharmacol 566(1-3): 11-19.
41. Sun W, Ding DL, Wang P, Sun J, Jin X, Salvi RJ (2004) Substance P inhibits potassium and calcium currents in inner ear spiral ganglion neurons. Brain Res 1012(1-2): 82-92.